Cargando…
CYLD negatively regulates cell-cycle progression by inactivating HDAC6 and increasing the levels of acetylated tubulin
CYLD is a tumour-suppressor gene that is mutated in a benign skin tumour syndrome called cylindromatosis. The CYLD gene product is a deubiquitinating enzyme that was shown to regulate cell proliferation, cell survival and inflammatory responses, mainly through inhibiting NF-κB signalling. Here we sh...
Autores principales: | Wickström, Sara A, Masoumi, Katarzyna C, Khochbin, Saadi, Fässler, Reinhard, Massoumi, Ramin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2775896/ https://www.ncbi.nlm.nih.gov/pubmed/19893491 http://dx.doi.org/10.1038/emboj.2009.317 |
Ejemplares similares
-
CYLD and SUMO in neuroblastoma therapy
por: Masoumi, Katarzyna Chmielarska, et al.
Publicado: (2016) -
Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma
por: Massoumi, Ramin, et al.
Publicado: (2009) -
Tumor Suppressor Function of CYLD in Nonmelanoma Skin Cancer
por: Masoumi, K. C., et al.
Publicado: (2011) -
NLK-mediated phosphorylation of HDAC1 negatively regulates Wnt signaling
por: Masoumi, Katarzyna Chmielarska, et al.
Publicado: (2017) -
UVB radiation represses CYLD expression in melanocytes
por: Kuphal, Silke, et al.
Publicado: (2017)